Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • REGENERON PHARMACEUTICALS Financial Overview

  • Income Statement: REGN

      2008 2007 Change ( 2007 - 2008  )
    Net Sales/Revenues 238.46 M 125.02 M 113.43 M 47.57%
    Gross Profit -40.48 M -76.59 M 36.11 M -89.19%
    Net Income Before Extra Items/Preferred Div -82.71 M -105.60 M 22.89 M -27.68%
    Operating Income -89.83 M -114.45 M 24.62 M -27.41%
  • Cash Flow: REGN

      2008 2007 Change ( 2007 - 2008  )
    Net Cash Flow - Financing -192.86 M 319.40 M -512.26 M 265.61%
    Net Cash Flow - Investing -30.82 M 85.72 M -116.54 M 378.19%
    Net Cash Flow/Operating Activities -89.09 M 27.37 M -116.46 M 130.73%
  • Balance Sheet: REGN

      2008 2007 Change ( 2007 - 2008  )
    Total Assets 670.04 M 936.26 M -266.22 M -39.73%
    Total Liabilities 251.19 M 475.99 M -224.80 M -89.50%
    Shareholders Equity 418.85 M 460.27 M -41.42 M -9.89%
  • Key Ratios / Statistics: REGN

    • Valuation

      Price/Earnings (TTM) -17.49
      Price/Sales (TTM) 6.07
      Price/Book (MRQ) 3.68
      Price/Cash Flow (TTM) -60.69
    • Profitability

      Gross Margin -16.98
      Operating Margin -37.67
      Profit Margin -34.69
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 6.09
      Current Ratio (MRQ) 4.04
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) -18.95
      Return on Assets (TTM) -7.99
      Return on Investments (TTM) -14.40